FIELD: medicine.
SUBSTANCE: there are determined maximum and/or average diametres of malignant cell nuclei, and/or their perimeter, and/or their area, and/or their volume, and/or an index form and-or an index oblongness, and/or the presence or the absence of nucleoli of the malignant cell nuclei. The presence or the absence of the nucleoli of the malignant cell nuclei are detected in certain magnification, while cariometry is enabled with a certain minimum number of the hypernephroma cell nuclei.
EFFECT: application of the method allows higher accuracy and specificity of determining a histologic malignance grade of non-metastatic hypernephroma in the patients following nephrectomy or partial nephrectomy with a new growth.
3 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF ONCOLOGICAL SURVIVAL RATE IN PATIENTS WITH NONMETASTATIC RENAL CELL CARCINOMA AFTER MALIGNANT NEPHRECTOMY OR PARTIAL NEPHRECTOMY | 2010 |
|
RU2438127C1 |
METHOD FOR MAKING DIFFERENTIAL DIAGNOSIS OF VARIOUS VARIANTS OF PAPILLARY THYROID GLAND CARCINOMA | 1997 |
|
RU2132064C1 |
METHOD FOR PREDICTION OF CLINICAL OUTCOME IN PATIENTS WITH METASTATIC KIDNEY CANCER | 2015 |
|
RU2589286C1 |
METHOD FOR PREDICTING SURFACE TRANSITIONAL CELL CARCINOMAS OF URINARY BLADDER | 2006 |
|
RU2321856C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HYPERPLASIA, INTRAEPITHELIAL NEOPLASIAS AND CERVIX UTERI CANCER | 2005 |
|
RU2321859C2 |
METHOD FOR PREDICTING EFFICIENCY OF OPERATIVE-RADIATION AND OPERATIVE-THERMORADIATION TREATMENT OF MAMMARY GLAND CANCER | 2000 |
|
RU2214593C2 |
IMPROVED ADJUVANT THERAPY OF G250 EXPRESSING TUMOURS | 2005 |
|
RU2519340C2 |
CYTOMETRIC DIAGNOSIS METHOD FOR PREDICTING PROSTATE TUMOR DISEASES | 2006 |
|
RU2322676C1 |
IMPROVED SUPPORTING THERAPY OF TUMOURS EXPRESSING G250 | 2005 |
|
RU2371198C2 |
METHOD FOR CLEAR CELL RENAL CANCER SIMULATION | 2016 |
|
RU2615860C1 |
Authors
Dates
2011-08-10—Published
2010-04-05—Filed